European Journal of Pharmaceutical Sciences

Papers
(The H4-Index of European Journal of Pharmaceutical Sciences is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis322
Editorial Board212
Aerosol delivery of inhalation devices with different add-on connections to invasively ventilated COPD subjects: An in-vivo study117
CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo98
Evaluation of Transmission Raman spectroscopy and NIR Hyperspectral Imaging for the assessment of content uniformity in solid oral dosage forms✰95
Opportunities of topical drug products in a changing dermatological landscape89
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin86
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study73
Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model66
Pre-miRNA-149 G-quadruplex as a molecular agent to capture nucleolin62
Development of cationic Isometamidium chloride loaded long-acting lipid nanoformulation: optimization, cellular uptake, pharmacokinetics, biodistribution, and immunohistochemical evaluation59
Molecular characteristics of several drugs evaluated from solvent/water partition measurements: Solvation parameters and intramolecular hydrogen bond indicator54
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy53
Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue53
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases52
In situ evaluation of spatiotemporal distribution of doxorubicin from Drug-eluting Beads in a tissue mimicking phantom51
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways50
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer50
1-MT grafted carboxymethyl chitosan and its nanoparticles: Preparation, characterization and evaluation50
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material49
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma49
Mechanism insight on drug skin delivery from polyurethane hydrogels: Roles of molecular mobility and intermolecular interaction49
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification46
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: In vitro test and in vivo toxicity assessment in Zebrafish embryos46
Development of long-acting rivastigmine drug-in-adhesive patch utilizing ion-pair strategy and characterization of controlled release mechanism45
Dissolving microneedles with antibacterial functionalities: A systematic review of laboratory studies44
Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel44
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets43
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system43
3D printed extended-release hydrochlorothiazide tablets43
Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation41
Microparticles and multi-unit systems for advanced drug delivery41
A new nanosuspension prepared with wet milling method for oral delivery of highly variable drug Cyclosporine A: development, optimization and in vivo evaluation38
Role of exosomes in bone and joint disease metabolism, diagnosis, and therapy38
UNGAP best practice for improving solubility data quality of orally administered drugs38
Low-dose apatinib in subjects with renal impairment: A pharmacokinetics study37
Advanced interpenetrating polymer networks for innovative gastroretentive formulations targeting Helicobacter pylori gastric colonization36
0.087519884109497